Total Funding
46
Total FundingGrant raised
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Neuromersiv offers clinically designed, virtual reality-based neurorehabilitation solutions.
- Dylan Karavadra: Business Development Manager
- Anshul Dayal: Co-Founder & CEOPast Role: Neuromersiv, Co-Founder & CTO
About the Company
Neuromersiv is a Sydney-based digital health company with the aim of treating chronic neurological conditions using immersive virtual reality (VR). Neuromersiv's first product, Ulysses™ is a clinically designed, Australian TGA and UK MHRA-approved VR-based upper-limb therapy system that empowers stroke, spinal cord, and acquired brain injury
survivors by helping them regain lost independence and quality of life. Ulysses enhances rehabilitation through clinically validated, task-specific training in immersive VR to maximise engagement, compliance, and functional recovery.
